Neuronal types expressing μ‐ and δ‐opioid receptor mRNA in the rat hippocampal formation

Opioids are thought to control the excitability of hippocampal principal neurons indirectly by inhibiting GABAergic interneurons. However, direct inhibition of hippocampal principal neurons by opioids has also been reported. To understand better the neuromodulatory role of opioids in rat hippocampal circuits, we analyzed types of μ‐ and δ‐opioid receptor (MOR, DOR)‐expressing hippocampal neurons. Most MOR‐immunoreactive neurons in the granular and pyramidal cell layers exhibited multipolar morphologies characteristic of GABAergic neurons. Virtually all neurons in the hippocampal formation expressing high MOR mRNA levels cocontained the mRNA for glutamic acid decarboxylase (GAD). Most parvalbumin‐, several calretinin‐, and several pre‐proenkephalin‐containing neurons expressed the MOR gene in the hippocampal formation. Expression of high DOR mRNA levels was restricted to GAD‐positive neurons in the principal cell layers, oriens layer and hilus. More than 90% of the parvalbumin‐positive neurons in the hippocampal formation strongly expressed the DOR gene. Granule cells expressing vesicular glutamate transporter 1 (VGLUT1) mRNA contained very low MOR and DOR transcript levels. In VGLUT1‐positive pyramidal cells, weak DOR but no MOR gene expression was detected. Whereas most somatostatinergic hilar neurons were negative for MOR and DOR mRNA, somatostatinergic oriens layer neurons frequently expressed these receptors. Taken together, weak expression of MOR and DOR genes in hippocampal principal cells is in concordance with direct opioid‐mediated inhibition of principal cells. However, strong expression of the MOR and DOR genes in the hippocampus is restricted to γ‐aminobutyric acid (GABA)ergic neurons, with DORs being selectively expressed in the parvalbumin‐ and somatostatin‐containing subpopulations. Activation of MOR and/or DOR in parvalbumin‐ and somatostatin‐containing neurons, which provide GABAergic inhibition to the perisomatic and distal dendritic regions of principal cells, respectively, is likely to facilitate principal cell excitation. J. Comp. Neurol. 469:107–118, 2004. © 2003 Wiley‐Liss, Inc.

[1]  T. Kosaka,et al.  Immunocytochemical characterization of hippocamposeptal projecting GABAergic nonprincipal neurons in the mouse brain: a retrograde labeling study , 2002, Brain Research.

[2]  C. Culmsee,et al.  A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.

[3]  M. Schäfer,et al.  Identification of the Differentiation-Associated Na+/PI Transporter as a Novel Vesicular Glutamate Transporter Expressed in a Distinct Set of Glutamatergic Synapses , 2002, The Journal of Neuroscience.

[4]  R. S. Sloviter,et al.  Commissurally projecting inhibitory interneurons of the rat hippocampal dentate gyrus: A colocalization study of neuronal markers and the retrograde tracer fluoro‐gold , 2001, The Journal of comparative neurology.

[5]  V. Höllt,et al.  C-terminal Splice Variants of the Mouse μ-Opioid Receptor Differ in Morphine-induced Internalization and Receptor Resensitization* , 2001, The Journal of Biological Chemistry.

[6]  J. Storm-Mathisen,et al.  The Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse , 2001, Neuron.

[7]  F. Fujiyama,et al.  Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex , 2001, The Journal of comparative neurology.

[8]  C. Culmsee,et al.  Adaptive Plasticity in Tachykinin and Tachykinin Receptor Expression after Focal Cerebral Ischemia Is Differentially Linked to GABAergic and Glutamatergic Cerebrocortical Circuits and Cerebrovenular Endothelium , 2001, The Journal of Neuroscience.

[9]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[10]  L. Devi,et al.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  Christian Rosenmund,et al.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons , 2000, Nature.

[12]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[13]  R. Fremeau,et al.  Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. , 2000, Science.

[14]  M. Krug,et al.  Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of μ-opioid receptor-deficient mice , 2000, Neuropharmacology.

[15]  C. Drake,et al.  Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation , 1999, Brain Research.

[16]  G. Siggins,et al.  Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism. , 1999, Journal of neurophysiology.

[17]  C. Lupica,et al.  Opioid Receptor Subtype Expression Defines Morphologically Distinct Classes of Hippocampal Interneurons , 1999, The Journal of Neuroscience.

[18]  G. Buzsáki,et al.  Interneurons of the hippocampus , 1998, Hippocampus.

[19]  G Buzsáki,et al.  GABAergic Cells Are the Major Postsynaptic Targets of Mossy Fibers in the Rat Hippocampus , 1998, The Journal of Neuroscience.

[20]  T. Freund,et al.  Enkephalin‐containing interneurons are specialized to innervate other interneurons in the hippocampal CA1 region of the rat and guinea‐pig , 1998, The European journal of neuroscience.

[21]  M. Wessendorf,et al.  Relationship of μ‐ and δ‐opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits , 1998 .

[22]  M. Wessendorf,et al.  CNS GABA neurons express the μ‐opioid receptor: immunocytochemical studies , 1997, Neuroreport.

[23]  S. Schulz,et al.  Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system , 1997, Neuroscience.

[24]  T. Milner,et al.  Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus , 1997 .

[25]  T. Freund,et al.  Interneurons Containing Calretinin Are Specialized to Control Other Interneurons in the Rat Hippocampus , 1996, The Journal of Neuroscience.

[26]  T. Kaneko,et al.  Immunohistochemical localization of μ‐opioid receptors in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[27]  T. Freund,et al.  Synaptic Input of Horizontal Interneurons in Stratum Oriens of the Hippocampal CA1 Subfield: Structural Basis of Feed‐back Activation , 1995, The European journal of neuroscience.

[28]  T. Milner,et al.  Ultrastructural heterogeneity of enkephalin‐containing terminals in the rat hippocampal formation , 1995, The Journal of comparative neurology.

[29]  H. Loh,et al.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  C. Lupica Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[32]  C. Houser,et al.  Localization of mRNAs encoding two forms of glutamic acid decarboxylase in the rat hippocampal formation , 1994, Hippocampus.

[33]  B. Morris,et al.  Nitric oxide alters proenkephalin and prodynorphin gene expression in hippocampal granule cells , 1994, Neuroscience.

[34]  M. Chesselet,et al.  Expression of Mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level , 1994, The Journal of comparative neurology.

[35]  G. Siggins,et al.  Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  M. Satoh,et al.  Molecular cloning and in situ hybridization histochemistry for rat μ-opioid receptor , 1994, Neuroscience Research.

[37]  P. Somogyi,et al.  Subdivisions in the Multiple GABAergic Innervation of Granule Cells in the Dentate Gyrus of the Rat Hippocampus , 1993, The European journal of neuroscience.

[38]  T. Freund,et al.  Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: Their immunoreactivity for GABA and projection to the medial septum , 1992, Neuroscience.

[39]  H. Akil,et al.  Atypical prodynorphin gene expression in corticosteroid-producing cells of the rat adrenal gland. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Henriksen,et al.  Enkephalin enhances responsiveness to perforant path input while decreasing spontaneous activity in the dentate gyrus , 1987, Neuroscience Letters.

[41]  L. Schmued,et al.  A GABAergic inhibitory component within the hippocampal commissural pathway , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[43]  K. Stengaard-Pedersen,et al.  Localization of enkephalin and cholecystokinin immunoreactivities in the perforant path terminal fields of the rat hippocampal formation , 1984, Brain Research.

[44]  W. Zieglgänsberger,et al.  Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Brecha,et al.  Localization of enkephalin‐like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus , 1981, The Journal of comparative neurology.

[46]  R. Nicoll,et al.  Enkephalin blocks inhibitory pathways in the vertebrate CNS , 1980, Nature.

[47]  T. Dunwiddie,et al.  Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. Effects on pyramidal cell activity , 1980, Brain Research.

[48]  F. Bloom,et al.  Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. , 1979, Science.

[49]  C. Ribak,et al.  GABAergic cells in the dentate gyrus appear to be local circuit and projection neurons , 2004, Experimental Brain Research.

[50]  C. Drake,et al.  Mu opioid receptors are in discrete hippocampal interneuron subpopulations , 2002, Hippocampus.

[51]  M. Wessendorf,et al.  Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. , 1998, The Journal of comparative neurology.

[52]  T. Milner,et al.  Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. , 1997, The Journal of comparative neurology.

[53]  C. Chavkin,et al.  Endogenous opioid regulation of hippocampal function. , 1996, International review of neurobiology.

[54]  M. Satoh,et al.  Molecular cloning and in situ hybridization histochemistry for rat mu-opioid receptor. , 1994, Neuroscience research.

[55]  H. Akil,et al.  Proenkephalin messenger RNA is expressed both in the rat anterior and posterior pituitary. , 1990, Neuroendocrinology.

[56]  R. Angerer,et al.  Demonstration of tissue-specific gene expression by in situ hybridization. , 1987, Methods in enzymology.